Lipid Nanoparticles

Abstract Small interfering RNA (siRNA)-loaded lipid nanoparticles (LNPs) are a promising modality for gene silencing therapies. Pulmonary delivery offers an...

Abstract The present study aimed to design, optimize, and evaluate enteric-coated nanocarriers to enhance the oral bioavailability of Rifaximin, a...

Abstract Solid lipid nanoparticles (SLNs) exhibit excellent potential as a drug delivery system in treating several cancers including gastrointestinal (GI)...

Abstract Endometriosis (EM) is a gynaecological disorder for which drug combinations such as atorvastatin (ATV) and silybin (SB) hold therapeutic...

Abstract During the pandemic, lipid nanoparticles (LNPs) became widely established as RNA nanocarriers, and hold the promise of future targeting...

Abstract Effective buccal drug delivery is limited by the barrier properties of the mucosa, necessitating innovative systems to enhance permeability...

Abstract Cancer remains to be one of the most life-threatening diseases with high rates of mortality and morbidity. The major...

Abstract Lipid-based formulations (LBFs) play a crucial role in enhancing the oral bioavailability of poorly water-soluble drugs by leveraging lipid...

Abstract Hybrid lipid nanocapsules (hLNCs) represent a promising platform for mRNA delivery with the added benefit of ambient-temperature stabilization. Conventional...

Abstract Ezetimibe is a cholesterol absorption inhibitor widely used in the treatment of dyslipidemia. However, its clinical efficacy is limited...